Brazil Gets Record Discount on Bristol Anti-HIV Drug

Law360, New York (November 14, 2003, 12:00 AM EST) -- Brazil's health ministry said Friday it had negotiated a record 76% discount for Bristol-Myers Squibb's new anti-AIDS drug Atazanavir without threatening to strip the drug's patent, according to the Associated Press.

Under the deal, Brazil will purchase each capsule of Atazanavir for $3.25 well below the manufacturer's price of $13.80, the AP reported.

Brazil provides a cocktail of anti-AIDS medicines free of charge to anyone who needs them. The country makes its own generic versions of many drugs, ignoring patents issued before 1997 when the country...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.